NAV
$41.69
AUM
$1.2B
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.59
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +8.97% | +0.48% | +2.25% | +22.26% | +21.65% | - |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | TSM | Taiwan Semiconductor Manufacturing Co Ltd ADR | 4.87% |
| 2 | ASML | ASML Holding NV ADR | 3.55% |
| 3 | BMO.TO | Bank of Montreal | 3.20% |
| 4 | NTR.TO | Nutrien Ltd | 3.18% |
| 5 | BABA | Alibaba Group Holding Ltd ADR | 3.14% |
| 6 | AZN.L | AstraZeneca PLC | 3.07% |
| 7 | SIEGY | Siemens AG ADR | 2.98% |
| 8 | MUFG | Mitsubishi UFJ Financial Group Inc ADR | 2.95% |
| 9 | AMX | America Movil SAB de CV ADR - Series B | 2.90% |
| 10 | CCO.TO | Cameco Corp | 2.83% |
Under normal circumstances, the fund invests at least 80% of its net assets (plus borrowings for investment purposes) in dividend-paying U.S. exchange-traded American depositary receipt (“ADR”) securities (“Equity Securities”) that are organized or located outside of the U.S. and will opportunistically utilize an “option strategy” consisting of writing (selling) U.S. exchange-traded covered call option contracts on such Equity Securities. It is non-diversified.
Inception Date: 2022-09-07